Cargando…
The type I interferon response in COVID-19: implications for treatment
Despite early reports to the contrary, there is increasing evidence that patients with severe COVID-19 have a robust type I interferon response, which contrasts with the delayed, possibly suppressed, interferon response seen early in infection. A robust type I interferon response could exacerbate hy...
Autores principales: | Lee, Jeong Seok, Shin, Eui-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824445/ https://www.ncbi.nlm.nih.gov/pubmed/32788708 http://dx.doi.org/10.1038/s41577-020-00429-3 |
Ejemplares similares
-
Dysregulation of type I interferon responses in COVID-19
por: Acharya, Dhiraj, et al.
Publicado: (2020) -
Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021) -
Roles of Type I and III Interferons in COVID-19
por: Choi, Hojun, et al.
Publicado: (2021) -
T cell-oriented strategies for controlling the COVID-19 pandemic
por: Noh, Ji Yun, et al.
Publicado: (2021) -
Type I and III interferon responses in SARS-CoV-2 infection
por: Kim, You-Me, et al.
Publicado: (2021)